Updated Oct 02, 2018

Non-invasive treatment for uterine fibroids using focused ultrasound

The innovation has no owner

CLAIM IT

Snapshot

Focus Areas:

Sexual and Reproductive Health

Sexual and Reproductive HealthSEE LESS

Implemented In:

Egypt

EgyptSEE LESS

1
Country Implemented In
Verified Funding
?

Innovation Description

Uterine fibroids, the most common female pelvic tumour, cause suffering in 25% of women aged 15-49. They cause pain, bleeding and often infertility. The dominant treatment is hysterectomy, involving surgical removal of the uterus. These invasive surgeries cause infertility, scarring and long recovery times. They require a sterile operating and recovery room. Ureteral injury major side effects occur in 2.2% to 3% of cases. Hospital stay is 2-5 days and return to normal activity is 44 days.

Milestones

Mar 2018
Funds RaisedVERIFIED
$75,000
Date Unknown
New Country
Egypt
Date Unknown
New Country
Egypt